⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MLTX News
MoonLake Immunotherapeutics Class A Ordinary Shares
MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX
prnewswire.com
MLTX
Levi & Korsinsky Notifies MoonLake Immunotherapeutics (MLTX) Investors - Lead Plaintiff Deadline on December 15, 2025
accessnewswire.com
MLTX
Levi & Korsinsky Notifies MoonLake Immunotherapeutics (MLTX) Investors - Lead Plaintiff Deadline on December 15, 2025
accessnewswire.com
MLTX
Pomerantz LLP Calls Attention to Class Action Against MoonLake Immunotherapeutics – MLTX
accessnewswire.com
MLTX
MoonLake Immunotherapeutics (MLTX) Faces Securities Fraud Allegations Over Drug Trial Results - Investors Are Notified to Contact BFA Law by December 15 Deadline
accessnewswire.com
MLTX
MoonLake Immunotherapeutics (MLTX) Faces Securities Class Action After Company Reported Disastrous Phase 3 Trial Data For Sole Drug Candidate -- Hagens Berman
prnewswire.com
MLTX
Investors in MoonLake Immunotherapeutics (MLTX): Protect Your Rights - Contact Levi & Korsinsky Before December 15, 2025
accessnewswire.com
MLTX
Class Action Filed Against MoonLake Immunotherapeutics (MLTX) Over Securities Violations - Contact Levi & Korsinsky Today
accessnewswire.com
MLTX
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at MoonLake Immunotherapeutics
businesswire.com
MLTX
The Gross Law Firm Notifies Shareholders of MoonLake Immunotherapeutics(MLTX) of a Class Action Lawsuit and an Upcoming Deadline
prnewswire.com
MLTX